Shubhranshu Shekhar

The United States spends more than $4 trillion per year on health care, largely conducted by private providers and reimbursed by insurers. A major concern in this system is overbilling and fraud by hospitals, who face incentives to misreport their claims to receive higher payments. In this work, we develop novel machine learning tools to identify hospitals that overbill insurers, which can be used to guide investigations and auditing of suspicious hospitals for both public and private health insurance systems. Using large‐scale claims data from Medicare, the US federal health insurance program for the elderly and disabled, we identify patterns consistent with fraud among inpatient hospitalizations. Our proposed approach for fraud detection is fully unsupervised, not relying on any labeled training data, and is explainable to end users, providing interpretations for which diagnosis, procedure, and billing codes lead to hospitals being labeled suspicious. Using newly collected data from the Department of Justice on hospitals facing anti‐fraud lawsuits, and case studies of suspicious hospitals, we validate our approach and findings. Our method provides a nearly fivefold lift over random targeting of hospitals. We also perform a postanalysis to understand which hospital characteristics, not used for detection, are associated with suspiciousness.

Given a cardiac-arrest patient being monitored in the ICU (intensive care unit) for brain activity, how can we predict their health outcomes as early as possible? Early decision-making is critical in many applications, e.g. monitoring patients may assist in early intervention and improved care. On the other hand, early prediction on EEG data poses several challenges: (i) earliness-accuracy trade-off; observing more data often increases accuracy but sacrifices earliness, (ii) large-scale (for training) and streaming (online decision-making) data processing, and (iii) multi-variate (due to multiple electrodes) and multi-length (due to varying length of stay of patients) time series. Motivated by this real-world application, we present BENEFITTER that infuses the incurred savings from an early prediction as well as the cost from misclassification into a unified domain-specific target called benefit. Unifying these two quantities allows us to directly estimate a single target (i.e. benefit), and importantly, (a) is efficient and fast, with training time linear in the number of input sequences, and can operate in real-time for decision-making, (b) can handle multi-variate and variable-length time-series, suitable for patient data, and (c) is effective, providing up to 2× time-savings with equal or better accuracy as compared to competitors.